As Chief Science Officer at Impossible Foods, Dr. John York, PhD, leads a fast-growing R&D team expected to double in size in 2021. Before joining the company in January, York served as the Chair of the Department of Biochemistry and a Professor of Biochemistry at Vanderbilt University from 2012 to 2020, where his laboratory paved...
From The Laboratory To Leadership turns science-minded managers into capable business leaders. That means they'll get the core management skills they need to fully leverage your company's human capital. In this four-day program, developed exclusively for managers in scientific fields, participants will learn how to … – Create productive teams in a challenging matrix-based team environment...
Effective Risk-Based Approaches to Optimize Clinical Quality and Achieve Inspection Readiness The pandemic forced clinical operations to adapt quickly, so research could continue, but what are the implications for quality? How did you ensure trial integrity as processes and operations were disrupted by new safety mandates? What documentation will regulators request for research that was impacted by the pandemic? We've...
In this exclusive webinar, Chris Dokomajilar, founder and CEO of DealForma, and Gilles Toulemonde, CEO of Inova, will present the trends they are tracking and speak to the ongoing digital transformation of biopharma dealmaking. They'll discuss what deals have been done so far in 2021, identify some of the difficulties that pharma companies are experiencing...
In light of the ongoing situation around COVID-19, the 2021 Symposium has been moved online, taking place on Tuesday 22nd June. We have been busy adapting the programme to maximize opportunities for making new connections. In addition to a fantastic programme of speakers, there will be interactive networking sessions and a forum for arranging individual meetings....
We’re looking for the next generation. New waves of cancer targets. Novel approaches to cell and gene therapies. Cutting-edge technologies set to change biopharma manufacturing. Even a new cohort of up-and-coming industry leaders. We’ll delve into all these subjects and more June 22-23 at Fierce’s next virtual event. And take a walk with our new...
The FAST Advisory Program provides selected startups and entrepreneurs with intensive team review and coaching to perfect their business model and product development plans, and to build a compelling commercialization strategy. Experienced entrepreneurs, product and business experts (which may include clinical development, regulatory, reimbursement and business development specialists) advise the selected Fellows during a ten-to-twelve...
The Chemical Engineering Congress 2021 will provide attendees with the latest chemical updates, the latest advances in chemical engineering and catalysis. This Chemical Engineering Conference will help chemists, and chemical engineers around the world to share their experiences and learn from best practices, strengthen chemical and catalytic collaborative research, and connect with each other. Outstanding...
BROCHURE
In this presentation we summarize 2020's cohort of new drugs approved by the FDA in 2020. Statistics on the overall cohort will be discussed, followed by a short summary of key features of approved drugs, and a few case studies highlighting interesting discovery or development stories from the cohort.
Equity and Dilution Basics Wednesday, June 23, 2021, 3-4pm Ever wonder about the difference between a convertible note and a SAFE? Here’s your chance to learn from a veteran venture lawyer about all of the options that founders have for financing their businesses with equity. Participants will also get a walk-through on how dilution works...
If you are interested in learning more about how VC investing works, what their process is for engaging with a life science startup, and how they manage their portfolios; then you will not want to miss our next event. Please join us on June 23rd from 4-5PM EDT for a talk with Riley Rodgers from...
